Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BAND
1151
Bandwidth Inc
BAND
$1.67B
| $5.02M | ﹤0.01% |
39,500
+7,100
| +22% | +$717K |
|
1152
First Hawaiian
FHB
$3.36B
| $5M | ﹤0.01% |
290,067
+36,000
| +14% | +$604K |
|
1153
Capri Holdings
CPRI
$1.77B
| $5M | ﹤0.01% |
319,700
-268,762
| -46% | -$3.98M |
|
1154
MGE Energy Inc
MGEE
$3.07B
| $4.99M | ﹤0.01% |
77,350
+10,100
| +15% | +$659K |
|
1155
FormFactor
FORM
$10.1B
| $4.99M | ﹤0.01% |
170,000
+23,200
| +16% | +$572K |
|
|
EPAY
1156
DELISTED
Bottomline Technologies Inc
EPAY
| $4.99M | ﹤0.01% |
98,200
+13,000
| +15% | +$581K |
|
1157
Sabre
SABR
$831M
| $4.97M | ﹤0.01% |
616,700
-598,960
| -49% | -$4.25M |
|
1158
NCR Voyix
VYX
$1.12B
| $4.94M | ﹤0.01% |
464,646
+61,288
| +15% | +$702K |
|
1159
Sensient Technologies
SXT
$5.53B
| $4.93M | ﹤0.01% |
94,500
+12,400
| +15% | +$587K |
|
1160
Diodes
DIOD
$4.93B
| $4.92M | ﹤0.01% |
97,100
+13,000
| +15% | +$622K |
|
1161
Ingevity
NGVT
$2.62B
| $4.91M | ﹤0.01% |
93,390
+12,300
| +15% | +$584K |
|
1162
Cleveland-Cliffs
CLF
$6.99B
| $4.9M | ﹤0.01% |
888,440
+119,200
| +15% | +$580K |
|
1163
ESCO Technologies
ESE
$7.78B
| $4.9M | ﹤0.01% |
58,000
+7,600
| +15% | +$600K |
|
1164
AutoNation
AN
$6.9B
| $4.88M | ﹤0.01% |
129,800
+26,000
| +25% | +$941K |
|
|
CRON
1165
Cronos Group
CRON
$1.17B
| $4.86M | ﹤0.01% |
812,700
+73,000
| +10% | +$446K |
|
1166
Equinox Gold
EQX
$13.1B
| $4.86M | ﹤0.01% |
437,728
+147,200
| +51% | +$1.32M |
|
1167
Kornit Digital
KRNT
$758M
| $4.85M | ﹤0.01% |
90,900
+12,500
| +16% | +$476K |
|
1168
EXL Service
EXLS
$5.36B
| $4.82M | ﹤0.01% |
380,340
+49,500
| +15% | +$583K |
|
|
SAGE
1169
DELISTED
Sage Therapeutics
SAGE
| $4.82M | ﹤0.01% |
115,800
+15,300
| +15% | +$555K |
|
1170
Helmerich & Payne
HP
$4.29B
| $4.8M | ﹤0.01% |
246,100
+35,800
| +17% | +$698K |
|
|
SINA
1171
DELISTED
Sina Corp
SINA
| $4.8M | ﹤0.01% |
133,673
+25,300
| +23% | +$851K |
|
1172
Howard Hughes
HHH
$3.98B
| $4.79M | ﹤0.01% |
96,718
+13,218
| +16% | +$666K |
|
1173
Associated Banc-Corp
ASB
$6.07B
| $4.78M | ﹤0.01% |
349,240
+38,900
| +13% | +$529K |
|
1174
Winnebago Industries
WGO
$915M
| $4.76M | ﹤0.01% |
71,500
+9,400
| +15% | +$480K |
|
|
TPTX
1175
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.76M | ﹤0.01% |
73,700
+38,900
| +112% | +$2.24M |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.